Multimodal drug infiltration during bone marrow aspiration. A randomized dubble blind controlled study
- Conditions
- Procedure pain for bone marrow aspiration, and painscore during 24 hour after aspiration
- Registration Number
- EUCTR2009-012479-93-SE
- Lead Sponsor
- ina Olofsson
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Twohundered adult males and females undergoing bone marrow aspiration who have signed informed consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Allergy for NSAID or local anesthetic, psychiatric disorders, demens, AV-block III, cardiac disorders, ulcus ventriculi and duodeni, renal disorders, coagulation disorders and patients who refuses to participate.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Secondary Objective: Pain score during first 24 hour after aspiration procedure;Primary end point(s): Painintensity (VAS) during bone marrow punkture. ;Main Objective: Pain score during bone marrow aspiration procedure
- Secondary Outcome Measures
Name Time Method